Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
.refereed research
 |  |  |  |  | 


Open AccessHighly AccessResearch

Signatures of human regulatory T cells: an encounter with old friends and new players

Susanne Pfoertner1 email, Andreas Jeron1 email, Michael Probst-Kepper2 email, Carlos A Guzman3 email, Wiebke Hansen1 email, Astrid M Westendorf1 email, Tanja Toepfer1 email, Andres J Schrader4 email, Anke Franzke5 email, Jan Buer1,6 email and Robert Geffers1 email

1Department of Mucosal Immunity, German Research Centre for Biotechnology, Braunschweig, Germany

2Volkswagen Foundation Junior Research Group, Department of Visceral and Transplant Surgery, Hanover Medical School, Hanover, Germany

3Department of Vaccinology, German Research Centre for Biotechnology, Braunschweig, Germany

4Department of Urology, Philipps-University Medical School, Marburg, Germany

5Department of Hematology and Oncology, Hanover Medical School, Hanover, Germany

6Institute of Medical Microbiology, Hanover Medical School, Hanover, Germany

author email corresponding author email

Genome Biology 2006, 7:R54doi:10.1186/gb-2006-7-7-r54

Published: 12 July 2006

Subject areas: Immunology, Genome studies

Abstract

Background

Naturally occurring CD4+CD25+ regulatory T cells (TReg) are involved in the control of autoimmune diseases, transplantation tolerance, and anti-tumor immunity. Thus far, genomic studies on TReg cells were restricted to murine systems, and requirements for their development, maintenance, and mode of action in humans are poorly defined.

Results

To improve characterization of human TReg cells, we compiled a unique microarray consisting of 350 TReg cell associated genes (Human TReg Chip) based on whole genome transcription data from human and mouse TReg cells. TReg cell specific gene signatures were created from 11 individual healthy donors. Statistical analysis identified 62 genes differentially expressed in TReg cells, emphasizing some cross-species differences between mice and humans. Among them, several 'old friends' (including FOXP3, CTLA4, and CCR7) that are known to be involved in TReg cell function were recovered. Strikingly, the vast majority of genes identified had not previously been associated with human TReg cells (including LGALS3, TIAF1, and TRAF1). Most of these 'new players' however, have been described in the pathogenesis of autoimmunity. Real-time RT-PCR of selected genes validated our microarray results. Pathway analysis was applied to extract signaling modules underlying human TReg cell function.

Conclusion

The comprehensive set of genes reported here provides a defined starting point to unravel the unique characteristics of human TReg cells. The Human TReg Chip constructed and validated here is available to the scientific community and is a useful tool with which to study the molecular mechanisms that orchestrate TReg cells under physiologic and diseased conditions.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.